Figure 4From: Association of RSV-related hospitalization and non-compliance with Palivizumab among commercially insured infants: a retrospective claims analysis Hazards for RSV-related hospitalization associated with palivizumab non-compliance for select population subsets*. *Data representing CLD have been omitted from this graph due to small sample size and large confidence interval (3.3 – 79.9).Back to article page